Phibro Animal Health | PAHC - Ebit


Phibro Animal Health reported $54.99M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Align Technology USD 193.04M 1.72M Sep/2026
ANI Pharmaceuticals USD 51.84M 12M Sep/2026
Aurora Cannabis CAD -3.17M 10.29M Jun/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Canopy Growth CAD -2.03M 143.62M Jun/2026
Corcept Therapeutics USD 114.72M 73.42M Sep/2026
Eli Lilly USD 13.09B 635M Sep/2026
Henry Schein USD 205M 5M Sep/2026
Idexx Laboratories USD 402.35M 23.22M Sep/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Merck USD 7.33B 6.49B Sep/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Pacira USD 2.57B 2.56B Sep/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 52.52M 22.97M Jun/2026
Supernus Pharmaceuticals USD -21.04M 14.21M Jun/2026
Zoetis USD 1.03B 88M Sep/2026